Cargando…
Corrigendum: Progression-free survival and time to progression as potential surrogate endpoints for overall survival in chemoradiotherapy trials in limited-stage small-cell lung cancer: A systematic review and meta-analysis
| Autores principales: | , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Frontiers Media S.A.
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9462661/ https://www.ncbi.nlm.nih.gov/pubmed/36091135 http://dx.doi.org/10.3389/fonc.2022.1007862 |
| _version_ | 1784787236553752576 |
|---|---|
| author | Yang, Yin Wang, Jianyang Wang, Wenqing Zhang, Tao Zhao, Jingjing Wang, Yu Li, Yexiong Wang, Luhua Bi, Nan |
| author_facet | Yang, Yin Wang, Jianyang Wang, Wenqing Zhang, Tao Zhao, Jingjing Wang, Yu Li, Yexiong Wang, Luhua Bi, Nan |
| author_sort | Yang, Yin |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-9462661 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | Frontiers Media S.A. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-94626612022-09-10 Corrigendum: Progression-free survival and time to progression as potential surrogate endpoints for overall survival in chemoradiotherapy trials in limited-stage small-cell lung cancer: A systematic review and meta-analysis Yang, Yin Wang, Jianyang Wang, Wenqing Zhang, Tao Zhao, Jingjing Wang, Yu Li, Yexiong Wang, Luhua Bi, Nan Front Oncol Oncology Frontiers Media S.A. 2022-08-24 /pmc/articles/PMC9462661/ /pubmed/36091135 http://dx.doi.org/10.3389/fonc.2022.1007862 Text en Copyright © 2022 Yang, Wang, Wang, Zhang, Zhao, Wang, Li, Wang and Bi https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
| spellingShingle | Oncology Yang, Yin Wang, Jianyang Wang, Wenqing Zhang, Tao Zhao, Jingjing Wang, Yu Li, Yexiong Wang, Luhua Bi, Nan Corrigendum: Progression-free survival and time to progression as potential surrogate endpoints for overall survival in chemoradiotherapy trials in limited-stage small-cell lung cancer: A systematic review and meta-analysis |
| title | Corrigendum: Progression-free survival and time to progression as potential surrogate endpoints for overall survival in chemoradiotherapy trials in limited-stage small-cell lung cancer: A systematic review and meta-analysis |
| title_full | Corrigendum: Progression-free survival and time to progression as potential surrogate endpoints for overall survival in chemoradiotherapy trials in limited-stage small-cell lung cancer: A systematic review and meta-analysis |
| title_fullStr | Corrigendum: Progression-free survival and time to progression as potential surrogate endpoints for overall survival in chemoradiotherapy trials in limited-stage small-cell lung cancer: A systematic review and meta-analysis |
| title_full_unstemmed | Corrigendum: Progression-free survival and time to progression as potential surrogate endpoints for overall survival in chemoradiotherapy trials in limited-stage small-cell lung cancer: A systematic review and meta-analysis |
| title_short | Corrigendum: Progression-free survival and time to progression as potential surrogate endpoints for overall survival in chemoradiotherapy trials in limited-stage small-cell lung cancer: A systematic review and meta-analysis |
| title_sort | corrigendum: progression-free survival and time to progression as potential surrogate endpoints for overall survival in chemoradiotherapy trials in limited-stage small-cell lung cancer: a systematic review and meta-analysis |
| topic | Oncology |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9462661/ https://www.ncbi.nlm.nih.gov/pubmed/36091135 http://dx.doi.org/10.3389/fonc.2022.1007862 |
| work_keys_str_mv | AT yangyin corrigendumprogressionfreesurvivalandtimetoprogressionaspotentialsurrogateendpointsforoverallsurvivalinchemoradiotherapytrialsinlimitedstagesmallcelllungcancerasystematicreviewandmetaanalysis AT wangjianyang corrigendumprogressionfreesurvivalandtimetoprogressionaspotentialsurrogateendpointsforoverallsurvivalinchemoradiotherapytrialsinlimitedstagesmallcelllungcancerasystematicreviewandmetaanalysis AT wangwenqing corrigendumprogressionfreesurvivalandtimetoprogressionaspotentialsurrogateendpointsforoverallsurvivalinchemoradiotherapytrialsinlimitedstagesmallcelllungcancerasystematicreviewandmetaanalysis AT zhangtao corrigendumprogressionfreesurvivalandtimetoprogressionaspotentialsurrogateendpointsforoverallsurvivalinchemoradiotherapytrialsinlimitedstagesmallcelllungcancerasystematicreviewandmetaanalysis AT zhaojingjing corrigendumprogressionfreesurvivalandtimetoprogressionaspotentialsurrogateendpointsforoverallsurvivalinchemoradiotherapytrialsinlimitedstagesmallcelllungcancerasystematicreviewandmetaanalysis AT wangyu corrigendumprogressionfreesurvivalandtimetoprogressionaspotentialsurrogateendpointsforoverallsurvivalinchemoradiotherapytrialsinlimitedstagesmallcelllungcancerasystematicreviewandmetaanalysis AT liyexiong corrigendumprogressionfreesurvivalandtimetoprogressionaspotentialsurrogateendpointsforoverallsurvivalinchemoradiotherapytrialsinlimitedstagesmallcelllungcancerasystematicreviewandmetaanalysis AT wangluhua corrigendumprogressionfreesurvivalandtimetoprogressionaspotentialsurrogateendpointsforoverallsurvivalinchemoradiotherapytrialsinlimitedstagesmallcelllungcancerasystematicreviewandmetaanalysis AT binan corrigendumprogressionfreesurvivalandtimetoprogressionaspotentialsurrogateendpointsforoverallsurvivalinchemoradiotherapytrialsinlimitedstagesmallcelllungcancerasystematicreviewandmetaanalysis |